National Health Investors, Inc. (NYSE:NHI)‘s stock had its “hold” rating reaffirmed by stock analysts at KeyCorp in a note issued to investors on Sunday.

Several other equities analysts also recently weighed in on NHI. BidaskClub downgraded National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Bank of America Corporation downgraded National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 target price on the stock. in a research report on Monday, May 22nd. ValuEngine downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Zacks Investment Research downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, September 6th. Finally, Stifel Nicolaus lifted their target price on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $80.50.

Shares of National Health Investors (NYSE:NHI) opened at 79.99 on Friday. The company has a market capitalization of $3.28 billion, a price-to-earnings ratio of 20.54 and a beta of 0.56. The company’s 50 day moving average price is $78.56 and its 200-day moving average price is $75.95. National Health Investors has a 1-year low of $66.31 and a 1-year high of $81.29.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). The firm had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The business’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter last year, the business earned $1.22 earnings per share. On average, equities analysts forecast that National Health Investors will post $3.85 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/09/17/national-health-investors-inc-nhi-rating-reiterated-by-keycorp.html.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of National Health Investors stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares in the company, valued at $1,693,994.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 5.19% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. US Bancorp DE lifted its position in National Health Investors by 0.5% during the second quarter. US Bancorp DE now owns 8,836 shares of the real estate investment trust’s stock valued at $700,000 after purchasing an additional 44 shares in the last quarter. Woodmont Investment Counsel LLC lifted its position in shares of National Health Investors by 1.3% in the second quarter. Woodmont Investment Counsel LLC now owns 3,414 shares of the real estate investment trust’s stock valued at $270,000 after acquiring an additional 45 shares in the last quarter. Daiwa Securities Group Inc. lifted its position in shares of National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock valued at $232,000 after acquiring an additional 55 shares in the last quarter. Teacher Retirement System of Texas lifted its position in shares of National Health Investors by 2.0% in the second quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock valued at $253,000 after acquiring an additional 62 shares in the last quarter. Finally, QS Investors LLC lifted its position in shares of National Health Investors by 0.8% in the second quarter. QS Investors LLC now owns 7,934 shares of the real estate investment trust’s stock valued at $628,000 after acquiring an additional 62 shares in the last quarter. Institutional investors own 70.58% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.